Literature DB >> 1955375

Cytostatic effect of deoxyspergualin on a murine leukemia cell line L1210.

M Hiratsuka1, H Kuramochi, K Takahashi, T Takeuchi, M Oshimura.   

Abstract

The mode of antiproliferative action of deoxyspergualin (NKT-01) was examined. The growth-inhibitory effect on a murine leukemia cell line L1210 following treatment with NKT-01 was time-dependent, and there was little or no effect on the syntheses of DNA and RNA. Thus, the inhibitory activity of NKT-01 was not attributable to the inhibition of DNA and RNA syntheses. The influence of NKT-01 on cell cycle progression was studied by flow cytometric analysis. Bromodeoxyuridine/DNA distribution patterns in cells that were treated for 72 h, showed that the growth inhibition is due to the delay of cell cycle progression but not to cytotoxicity. This finding was also supported by evidence that the treated cells were re-proliferative in fresh medium. In addition, a majority of drug-treated cells was prevented from traversing from the G0/G1 phase to the S phase by 144 h or longer exposure to NKT-01. The results suggest that NKT-01 is cytostatic, preventing G0/G1-S progression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955375      PMCID: PMC5918251          DOI: 10.1111/j.1349-7006.1991.tb01758.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


fluorescein isothiocyanate bromodeoxyuridine trichloroacetate propidium iodide
  16 in total

1.  In vitro immunosuppressive effect of deoxymethylspergualin.

Authors:  H Jiang; S Takahara; Y Takano; M Machida; A Iwasaki; Y Kokado; H Kameoka; A Moutabarrik; M Ishibashi; T Sonoda
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

2.  Downregulation of c-myc RNA is not a prerequisite for reduced cell proliferation, but is associated with G1 arrest in B-lymphoid cell lines.

Authors:  J Lømo; H Holte; C de Lange Davies; E Ruud; M Laukas; E B Smeland; T Godal; H K Blomhoff
Journal:  Exp Cell Res       Date:  1987-09       Impact factor: 3.905

3.  Preclinical antitumor activity and pharmacological properties of deoxyspergualin.

Authors:  J Plowman; S D Harrison; M W Trader; D P Griswold; M Chadwick; M F McComish; D M Silveira; D Zaharko
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

4.  The antiproliferative action of deoxyspergualin is different from that induced by amine oxidase.

Authors:  H Kuramochi; M Hiratsuka; S Nagamine; K Takahashi; T Nakamura; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1988-02       Impact factor: 2.649

5.  Mechanism of action of 15-deoxyspergualin. I. Suppressive effect on the induction of alloreactive secondary cytotoxic T lymphocytes in vivo and in vitro.

Authors:  K Nishimura; T Tokunaga
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

6.  Deoxyspergualin directly suppresses antibody formation in vivo and in vitro.

Authors:  H Fujii; T Takada; K Nemoto; T Yamashita; F Abe; A Fujii; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1990-02       Impact factor: 2.649

7.  Effects of deoxyspergualin on hematopoiesis: studies of murine hematopoietic progenitor cell and peripheral blood cell levels.

Authors:  K Nemoto; M Hayashi; Y Sugawara; F Abe; T Takita; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1989-02       Impact factor: 2.649

8.  Immunosuppressive activities of deoxyspergualin. II. The effect on the antibody responses.

Authors:  M Makino; M Fujiwara; H Watanabe; T Aoyagi; H Umezawa
Journal:  Immunopharmacology       Date:  1987 Oct-Nov

9.  In vitro immunosuppressive properties of spergualins to murine T cell response.

Authors:  H Fujii; T Takada; K Nemoto; F Abe; A Fujii; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1989-05       Impact factor: 2.649

10.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

View more
  3 in total

1.  Inhibition of cell growth through inactivation of eukaryotic translation initiation factor 5A (eIF5A) by deoxyspergualin.

Authors:  Kazuhiro Nishimura; Yuji Ohki; Tomomi Fukuchi-Shimogori; Kaori Sakata; Kan Saiga; Takanobu Beppu; Akira Shirahata; Keiko Kashiwagi; Kazuei Igarashi
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

2.  Phase II study of deoxyspergualin in metastatic breast cancer.

Authors:  K Dhingra; V Valero; L Gutierrez; R Theriault; D Booser; F Holmes; A Buzdar; G Fraschini; G Hortobagyi
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

3.  Targeted Imaging Agent to HSP70 Induced In Vivo.

Authors:  Pradip Ghosh; Brian E O'Neill; King C Li
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.